Document:

EX-10.2

 [ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED
IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED
SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24b-2 OF
THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. 

EXHIBIT 10.2 

AMENDED AND RESTATED SUPPLY AGREEMENT 

THIS AMENDED AND RESTATED SUPPLY
AGREEMENT (THE “SUPPLY AGREEMENT”) is made effective as of the 21st day of April,
2014 (the “Effective Date”) by and between Cerus Corporation (“Cerus”), a Delaware corporation, having its principal place of business at 2550 Stanwell Drive, Concord, CA 94520, and Purolite Corporation
(“Purolite”), a Delaware corporation, having its principal place of business at 150 Monument Road, Bala Cynwyd, PA 19004. (Cerus and Purolite are each individually referred to in this Supply Agreement as a “Party” and,
collectively, as the “Parties”). 
 WITNESSETH 

WHEREAS, Cerus develops, markets and sells products and technology for the inactivation of pathogens in
blood and blood components, and Purolite is a global manufacturer and supplier of specialty resins; 

WHEREAS, the Parties desire to set forth the terms under which Cerus may purchase from Purolite [ *
] and [ * ] (collectively, the “Raw Materials”) made to Cerus specifications as further detailed, respectively in Exhibit A and Exhibit B attached hereto (the “Specifications”); and 

WHEREAS, the Raw Materials will be used in the manufacture of disposable products forming part of the INTERCEPT Blood
System for platelets and the INTERCEPT Blood System for plasma for sale by Cerus and its affiliates, and disposable products forming part of similar systems for sale by third parties (collectively, the “Products”). 

NOW THEREFORE, in consideration of the foregoing premises and the mutual covenants set
forth herein, Cerus and Purolite agree as follows: 
 1. PURCHASES 

1.1 Purchase and Sale. During the term of this Supply Agreement, Purolite shall sell to Cerus Raw Materials ordered pursuant to
Section 1.2 of this Agreement. Cerus may designate, from time to time, one or more third parties (hereinafter referred to individually as a “Designee”) that are authorized to receive, inspect and test shipments from Purolite
for such ordered Raw Materials pursuant to Section 2. 
 1.2 Forecasts/Purchase Orders. No later than the end of the third
quarter of each calendar year, Cerus will provide Purolite with written, non-binding rolling [ * ] month [ * ] forecasts of its requirements of Raw Materials for the following [ * ] (each a “Forecast”),
including requested delivery dates. On or before the end of each calendar quarter during the term of this Agreement, Cerus will provide a binding [ * ] order for the immediately following calendar quarter, with estimated delivery dates set
forth therein (“Purchase Order(s)”) and a non-binding [ * ] forecast, with estimated monthly delivery dates set forth therein. Within ten (10) business days after receipt of the Purchase Order, Purolite shall provide
confirmation of its ability to meet the monthly requirements in a Purchase Order, including the requested delivery dates set forth therein. All sales of Raw Materials shall be subject to the terms and conditions of this Agreement and, to the extent
they specify quantities, destinations and delivery dates, to Cerus’ Purchase Orders, as the case may be. 

 2. DELIVERY AND ACCEPTANCE 

2.1 Testing and Release of Raw Materials. Purolite shall ship a representative sample of each batch of Raw Materials produced with all
relevant documentation (including Batch Record and Certificate of Analysis) to Cerus’ or its Designee’s testing facility, as applicable, for testing as further detailed in the “Quality Obligations” provided in Exhibit
C attached hereto. If the analysis of the sample batch performed by Cerus or its Designee, as applicable, indicates that said batch does not meet Specifications or is otherwise non-conforming, Cerus shall provide written notification of such to
Purolite. A Certificate of Analysis shall be issued to Cerus for each accepted batch. 
 2.2 Shipment. Purolite shall, upon
notification by Cerus, ship released batches for said materials to the location designated by Cerus in the applicable purchase order, using a mutually agreed carrier. Freight terms are [ * ]. [ * ] will prepay and add the freight costs
from the Philadelphia Warehouse to the requested Cerus destination. Title and risk of loss to the Raw Materials shall pass to Cerus [ * ] by Purolite. Unless otherwise agreed to in writing, Cerus shall pay all shipping charges. Purolite shall
provide Cerus with all documentation necessary to accomplish shipment to such designated locations as further described in the Specifications. Should Purolite be unable to provide Raw Materials by the agreed upon date of shipment set forth in the
applicable purchase order within agreed upon lead time, Purolite will bear the premium freight cost (including airfreight) to deliver the Raw Materials to Cerus’ final destination, as specified in the purchase order. 

2.3 Quality Assurance. 

2.3.1 All Raw Materials shipped hereunder shall meet the Specifications and shall be subjected to a quality control inspection and final
release by Purolite in accordance with the Quality Obligations set forth in Exhibit C attached hereto, and Purolite shall maintain compliance with said Quality Obligations. If Cerus or said Designee, as applicable, rejects Products as a
result of Raw Materials non-conformance, Cerus shall notify Purolite in writing within 60 days. At Cerus option, and at Purolite’s expense, as the case may be, Cerus shall receive a credit, refund or replacement for such Raw Materials if the
non-conformance can be directly attributed to Purolite’s Raw Materials. 
 2.3.2 Purolite shall permit Cerus to review
periodically Purolite’s production and quality control procedures and records and to visit Purolite’s facilities at reasonable times with a representative of Purolite present in order to assure satisfaction of the requirements of this
Agreement. Purolite will also notify Cerus immediately of any inspection of its facilities by a federal, state or local regulatory agency as well as the results of such inspection. 

  
 [ * ] = CERTAIN
CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN
OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT
TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. 

Page 2 of 7 

CERUS–PUROLITE AGMT. 

 2.3.3 In the event that either Party receives any complaint regarding the Raw Materials,
it shall notify the other Party promptly. Purolite will be responsible for evaluating these complaints and responding to Cerus in writing. Cerus will make a preliminary evaluation of each complaint and will conduct all follow-up and communicating
which it deems appropriate. 
 3. PAYMENT 

3.1 Prices to be paid by Cerus (the “Prices”) are set forth on Exhibit D. Price adjustments and terms will be
determined by the formula and terms listed on Exhibit D.  
 3.2 Immediately following each shipment, Purolite shall invoice
Cerus for Raw Materials produced, released and shipped in accordance with this Agreement and pursuant to Cerus’ Purchase Order for that shipment. Cerus will pay the amount of the invoice within [ * ] days of shipment from Philadelphia
warehouse with proof of shipment. covered by such invoice sent by Purolite. 
 4. RAW MATERIAL CHANGES

 4.1 Purolite shall notify Cerus in advance and in writing of any proposed change in the following aspects of the Raw Materials
or their components: (i) composition or source of any raw material; (ii) method of producing, processing or testing; (iii) change in subcontractors for producing, processing or testing; (iv) site of manufacture; and/or
(v) labeling. No such change shall be made without Cerus’ prior written consent. 
 4.2 Purolite shall make
available to Cerus all developments or enhancements to the Products and other products that accomplish the same or similar functions as the Products. If Cerus shall agree in writing to accept any such enhancement, development or other product, it
shall be added as an amendment to the applicable Specifications or as a new Specification, as applicable. Changes in the price of Products as a result of enhancements or developments accepted by Cerus shall be mutually agreed in writing. 

5. FORCE MAJEURE 

Purolite shall not be liable for delays in performance or for non-performance of its obligations hereunder if prevented by unforeseeable causes
outside of its reasonable control. Without limiting the foregoing, such causes shall include but not be limited to, acts of God or the public enemy, fires, floods, earthquake, riots, boycotts, strikes, lock-outs, and delays in transportation or
shortage of supplies necessary for production, in each case where delays could not reasonably have been prevented. Upon discovering that timely performance will be delayed, Purolite will immediately notify Cerus of the nature of the delay and
Purolite’s disaster recovery plan along with timing expectations. Purolite will develop and furnish to Cerus a copy of a proposed disaster recovery plan promptly following execution of this Supply Agreement. 

  
 [ * ] = CERTAIN
CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN
OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT
TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. 

Page 3 of 7 

CERUS–PUROLITE AGMT. 

 6. WARRANTIES AND INDEMNIFICATIONS 

6.1 Purolite Warranties 

6.1.1 PUROLITE WARRANTS THAT PUROLITE TRANSFERS GOOD AND MARKETABLE TITLE TO THE RAW MATERIALS SOLD TO CERUS UNDER THIS AGREEMENT AS OF
THE TIME THAT PUROLITE SHIPS SUCH RAW MATERIALS. THE WARRANTIES IN THIS SECTION 6.1.1 ARE IN LIEU OF ALL OTHER WARRANTIES, EXPRESS OR IMPLIED, WHICH ARE HEREBY DISCLAIMED AND EXCLUDED BY PUROLITE, INCLUDING ANY WARRANTY OF MERCHANTABILITY OR FITNESS
FOR A PARTICULAR PURPOSE OR USE, OR ANY WARRANTY ARISING FROM COURSE OF PERFORMANCE, COURSE OF DEALING OR USAGE OF TRADE. 
 6.1.2
All Raw Materials provided to Cerus are hereby guaranteed by Purolite, as of the date of shipment or delivery, to meet the Specifications and requirements specified by Cerus under this Supply Agreement and, to be, on such date, not adulterated or
misbranded. 
 6.2 Indemnification 

6.2.1 Cerus, will indemnify, defend and hold harmless Purolite, its affiliates, and their respective officers, directors, agents, and
employees (each a “Purolite Indemnified Party”) from and against any and all claims, actions and causes of action from third parties, and liabilities, losses, costs, damages or expenses (including reasonable attorney’s fees)
arising therefrom out of or in consequence of (i) the possession or use of any Products containing the Raw Materials, except to the extent caused by a matter covered by Purolite’s indemnity in Section 6.2.2; (ii) the death of or
bodily injury to any person on account of the use of any Product containing the Raw Materials, except to the extent caused by a matter covered by Purolite’s indemnity in Section 6.2.2; or, (iii) any claim that the Products violate a
patent or trademark. However, Cerus shall not be obligated to indemnify a Purolite Indemnified Party from any liability to the extent caused by a Purolite Indemnified Party’s negligence or misconduct. 

6.2.2 Purolite will indemnify, defend and hold harmless Cerus and its respective officers, directors, agents, employees and affiliates
(each a “Cerus Indemnified Party”) from and against any and all third party claims, actions, causes of action, liabilities, losses, costs, damages or expenses (including reasonable attorney’s fees) to the extent arising out of
or in consequence of any (a) claim of patent or trade secrets infringement which relates to the Raw Materials. However, Purolite shall not be obligated to indemnify a Cerus Indemnified Party from any liability to the extent caused by such Cerus
Indemnified Party’s negligence or misconduct. 
 6.2.3 Each Party agrees to give the other Party prompt written notice of any
claims, including any claims asserted or made by any governmental authority, for which the other might be liable under the foregoing indemnification, together with the opportunity to defend, negotiate and settle such claims. Such notice shall be
given to the other Party promptly after receipt of such claim. Failure to provide or promptly provide such notice shall not release the other Party 

  
 [ * ] = CERTAIN
CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN
OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT
TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. 

Page 4 of 7 

CERUS–PUROLITE AGMT. 

 
from any of its obligations hereunder except to the extent that the indemnifying Party is materially prejudiced by such failure. Each Party will cooperate fully with the other Party in defending
or otherwise resolving any such action, and each indemnified Party in any such action may at its option and expense be represented in such action. 

6.3 Insurance. Each Party shall obtain and keep in force during the term of this Agreement [ * ] comprehensive liability
insurance covering each occurrence of bodily injury (including death) and property damage in an amount of not less than $[ * ] combined in a single limit, including: 

(i) Products and Completed Operations Liability; and 

(ii) Contractual Liability. 

The insurance policy shall be endorsed to name the other Party as additional insured and to provide for written notification to the other
parties by the insurer not less than thirty (30) days prior to cancellation, expiration or modification. If requested in writing, a certificate of insurance evidencing compliance with this Section and referencing this Supply Agreement shall be
furnished to each Party. 
 7. DISCLOSURE OF INFORMATION; INTELLECTUAL
PROPERTY 
 7.1 Purolite shall maintain in confidence information received prior to and in the course of this
Agreement from Cerus or its Designee(s) relating to Cerus and its Products, including, but not limited to, Cerus’ supply chain and business activities (“Confidential Information”) and shall not disclose the same to any third
party or use the same except for the purposes of this Agreement. The term “Confidential Information” shall not be deemed to include information which: 

(a) is now, or hereafter becomes, through no act or failure to act on the part of Purolite, generally known or available; 

(b) is known by Purolite at the time of receiving such information, as evidenced by his or her written records; 

(c) is hereafter furnished to Purolite by a third party, as a matter of right and without restriction of disclosure; or 

(d) is the subject of a written permission to disclose provided by Cerus. 

Purolite understands and agrees that this Supply Agreement is not intended to grant Purolite any right, title, interest or license to use or disclose
Cerus’ Confidential Information and intellectual property, including, but not limited to Products designs and Specifications. 

  
 [ * ] = CERTAIN
CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN
OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT
TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. 

Page 5 of 7 

CERUS–PUROLITE AGMT. 

 7.2 Cerus understands and agrees that this Supply Agreement is not intended to grant Cerus
any right, title, interest or license to use Purolite’s manufacturing processes. 
 8. TERM; TERMINATION

 8.1 This Supply Agreement will have a term (the “Initial Term”) which will run for Eighty-Four
(84) months commencing on the Effective Date, subject to extension as provided in Section 8.2.  
 8.2 At the end of
the Initial Term and each renewal term, this Supply Agreement shall automatically renew from year to year for successive one (1) year periods, unless either Party shall have given the other Party written notice of non-renewal at least two years
prior to the last day of the Initial Term or renewal term, as the case may be. 
 8.3 If a Party materially breaches this
Supply Agreement and such breach remains uncured for a period of ninety (90) days after written notice containing details of the breach is delivered to the breaching Party, then the non-breaching Party may terminate this Supply Agreement as to
the breaching Party by further notice delivered no later than thirty (30) days after the expiration of the initial ninety (90) day cure period. 

8.4 The provisions of Articles 6 and 7 of this Supply Agreement shall survive termination of the Supply Agreement and remain in effect
in accordance with their terms. 
 9. MISCELLANEOUS 

9.1 Entire Agreement. This Supply Agreement contains the entire agreement between the Parties relating to the Raw Materials and
supersedes all prior agreements and negotiations between Cerus and Purolite regarding the same. None of the terms of this Supply Agreement shall be deemed to be waived or amended by any Party unless such a waiver or amendment specifically references
this Supply Agreement and is in writing signed by the Party to be bound. 
 9.2 Notices. All notices and demands required or
permitted to be given or made pursuant to this Supply Agreement shall be in writing and effective when personally given or when placed in an envelope and deposited in the United States mail postage prepaid and return receipt requested, or delivered
by a recognized commercial courier service, addressed as follows: 
 If to Cerus: 

Chief Executive Officer 
 Cerus
Corporation 
 2550 Stanwell Drive 

Concord, CA 94520 
 cc: Chief
Legal Officer by fax ([ * ]) 

  
 [ * ] = CERTAIN
CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN
OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT
TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. 

Page 6 of 7 

CERUS–PUROLITE AGMT. 

 If to Purolite: 

Ted Begg, Sales Mgr. 
 The
Purolite Company 
 150 Monument Road 

Bala Cynwyd, PA 19004 
 cc: Jacob
Brodie, Vice President by email [ * ] 
 or to such other address as to which either Party may notify the other. 

9.3 Assignment. This Supply Agreement shall be binding upon and inure to the benefit of the Parties, their successors and assigns. This
Supply Agreement shall be assignable: (i) by any Party to an affiliate of the Party, in whole or in part, without the consent of the other Party; (ii) by any Party with the written consent of the other Party; or (iii) by any Party
without the consent of the other Party to the purchaser of substantially all the assets of its business to which this Supply Agreement relates or to any corporate successor to a Party by merger, consolidation or otherwise. Any attempted assignment
that does not comply with the terms of this Section shall be void. Each Party shall cause this Supply Agreement to be assumed by any business organization that purchases its operations supporting this Supply Agreement or to any corporate successor
to a Party by merger, consolidation or otherwise. Despite any assignment under this Section, the Party making the assignment shall remain liable for its obligations as a Party to this Supply Agreement. 

9.4 Governing Law. This Supply Agreement is deemed to have been executed in and shall be governed by and construed in accordance with
the Uniform Commercial Code as enacted in the State of New York and other applicable laws of the State of New York. If particular portions of this Supply Agreement are ruled unenforceable, such portions shall be deleted and all other terms and
conditions of this Supply Agreement shall remain in full force and effect. 
 9.5 Independent Contractors; Relationship of Parties

 9.5.1 The relationship of the Parties under this Supply Agreement shall be and at all times remains one of independent
contractors. No Party is an employee, agent or legal representative of any other Party or shall have any authority to assume or create obligations on any other Party’s behalf. 

9.5.2 Cerus shall have the right to revoke any designation as a Designee made pursuant to Subsection 1.1 of this Agreement, which
revocation shall be effective thirty (30) days following written notice of such to Purolite. 
 9.5.3 Nothing herein shall be
construed as giving any Designee any rights, interest or claims hereunder or be entitled to any benefits under or on account of the Agreement as a third-party beneficiary or otherwise and the sole and intended beneficiaries of this Agreement and the
Supply Agreement are Cerus and Purolite. 

  
 [ * ] = CERTAIN
CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN
OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT
TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. 

Page 7 of 7 

CERUS–PUROLITE AGMT. 

 IN WITNESS WHEREOF, the
parties have executed this Supply Agreement in counterparts, effective as of the day and year first written above. 
  

			
	CERUS CORPORATION
		
	By:	 	/s/ Kevin D. Green
	Name:	 	Kevin D. Green
	Title:	 	Vice President, Finance and
		 	Chief Financial Officer

  

			
	PUROLITE CORPORATION
		
	By:	 	/s/ Jacob Brodie
	Name:	 	Jacob Brodie
	Title:	 	Vice President

  
 [ * ] = CERTAIN
CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN
OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT
TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. 

SIGNATURE PAGE 

CERUS –PUROLITE AGMT . 

 Exhibit A 

Specifications for [ * ] 

{Attached separately} 

[ * ] 

  
 [ * ] = CERTAIN
CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN
OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT
TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. 

EXHIBIT A 

CERUS –PUROLITE AGMT 

 Exhibit B 

Specifications for [ * ] 

{Attached separately} 

[ * ] 

  
 [ * ] = CERTAIN
CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN
OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT
TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. 

EXHIBIT B 

CERUS –PUROLITE AGMT 

 Exhibit C 

Quality Obligations 
 The following is to
set forth responsibilities of Cerus and Purolite with respect to Quality Obligations. 
 (A) Cerus (directly or through its Designee) Responsibilities:

  

	1.	Provide Purolite with current, approved regulatory documents including Specifications. 

  

	2.	Approve manufacturing batch records, review validation documents and other manufacturing documents as applicable. If changes are indicated, provide edited copies to Purolite to facilitate revision. 

 

	3.	Cerus will analyze pre-shipment samples of Product within [ * ] of receipt of said samples at the designated Cerus testing facility. Cerus will provide Purolite with the analysis data and if the Product is
approved, will provide a written release of the Product Lots for shipment to Cerus. If Product Lots are rejected, Cerus will provide an explanation of the rejection along with the analysis data. 

 

	4.	Inspect and test all Products shipped hereunder and notify Purolite of any Products that do not comply with the Specifications within sixty (60) days from delivery. Such notice shall specify the reasons for
rejection, and Cerus or Designee giving notice (as the case may be) shall thereafter (insofar as they are in its possession and with Purolite’s approval) return the rejected Products to Purolite at Purolite’s risk and expense. If Cerus or
its Designee (as the case may be) does not deliver such written notice of rejection within such sixty (60)-day period, Cerus shall be deemed to have accepted the shipment. In the event that Cerus or Designee (as the case may be) delivers notice to
Purolite that Cerus or said Designee has rejected any shipment, Cerus or said Designee (as the case may be) shall promptly make available to Purolite for examination and testing the Products contained in such rejected shipment (excluding units
consumed in such Designee testing), and Purolite shall, within ninety (90) days, replace the defective and non-conforming Products contained in such shipment and return such Products to Cerus or said Designee (as the case may be),
transportation and insurance prepaid. 

 (B) Purolite Responsibilities: 

 

	1.	Maintain specifications and test methods according to Purolite SOPs and where applicable, according to mutually agreed upon specifications. 

 

	2.	Sample and maintain reserve samples per the Specifications. 

  

	3.	Test and perform quality release of Raw Materials and finished products according to Purolite SOPs and approved specification requirements. 

  
 [ * ] = CERTAIN
CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN
OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT
TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. 

EXHIBIT C 

CERUS –PUROLITE AGMT 

	4.	Provide prior notification to and obtain written approval from Cerus Quality Assurance of any significant change to production or test records, Raw Material Specifications, test methods or location relating to
manufacture of Products. 

  

	5.	Perform testing as directed by approved master records, protocols, or validated analytical test procedures. 

  

	6.	Maintain reasonable manufacturing records as agreed to by Cerus. 

  

	7.	Perform cleaning and process validation as applicable per protocol (which shall be reviewed by Cerus prior to final approval by Purolite). 

 

	8.	Review and forward all deviation reports to Cerus for review as part of batch record documentation. 

  

	9.	Review and forward copy of Certificates of Analysis, and related documents, as required, to Cerus for review. 

  

	10.	Provide batch records and test records, as requested, to Cerus for review during audits. 

  

	11.	Provide evidence of ISO 9001 certification, if requested. 

  

	12.	Maintain facility and critical systems in a current state of compliance and validation per ISO 9001 requirements. 

  

	13.	Agree to regular audits (no more frequently than annually or for cause) by Cerus at mutually acceptable times. 

  

	14.	Support Cerus regulatory submissions by providing information requested in a timely manner provided such submissions do not require Purolite to provide Purolite Confidential Information or trade secrets.

  

	15.	Notify Cerus, within ten (10) business days, of pending ISO or FDA audits that may affect the supply of Raw Materials under this Agreement. Provide results of any ISO or FDA audit related to Cerus manufacturing.

  
 [ * ] = CERTAIN
CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN
OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT
TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. 

EXHIBIT C 

CERUS –PUROLITE AGMT 

 Exhibit D 

Pricing and Formula 
 [ * ] 

  
 [ * ] = CERTAIN
CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN
OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT
TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. 

EXHIBIT D 

CERUS –PUROLITE AGMTEX 10.2-6.30.14-10Q

Exhibit 10.2
COVANTA HOLDING CORPORATION 
RESTRICTED STOCK AWARD AGREEMENT

THIS AGREEMENT is made and entered into as of this ___ day of __________, 20__ (the “Grant Date”) by and between Covanta Holding Corporation, a Delaware corporation (the “Company”), and ______________________________ (the “Employee”), pursuant to the Covanta Holding Corporation 2014 Equity Award Plan (the “Plan”).  This Agreement and the award contained herein is subject to the terms and conditions set forth in the Plan, which are incorporated by reference herein, and the following terms and conditions:

1.    Award of Restricted Stock.  In consideration for the prior and continued service of Employee to Covanta Energy Corporation (“Covanta”), a wholly-owned subsidiary of the Company, and as part of the Long-Term Incentive Program of Covanta, as adopted by the Company, the Company hereby awards to the Employee, subject to the further terms and conditions set forth in this Agreement, _____________ shares (the “Restricted Stock”) of its common stock, $0.10 par value per share (the “Common Stock”), as of the Grant Date.
  
2.    Rights of Stockholder.  Employee shall have all of the rights of a stockholder with respect to the shares of Restricted Stock (including the right to vote the shares of Restricted Stock and the right to receive dividends with respect to the shares of Restricted Stock), except as provided in Section 3 and Section 6 hereof. 
3.    Restrictions on Transfer.  Except as otherwise provided in this Agreement, Employee may not sell, transfer, assign, pledge, encumber or otherwise dispose of any of the shares of Restricted Stock or the rights granted hereunder (any such disposition or encumbrance being referred to herein as a “Transfer”).  Any Transfer or purported Transfer by Employee of any of the shares of Restricted Stock shall be null and void and the Company shall not recognize or give effect to such Transfer on its books and records or recognize the person to whom such purported Transfer has been made as the legal or beneficial holder of such shares.  The shares of Restricted Stock shall not be subject to sale, execution, pledge, attachment, encumbrance or other process and no person shall be entitled to exercise any rights of Employee as the holder of such Restricted Stock by virtue of any attempted execution, attachment or other process until the restrictions imposed herein on the Transfer of the shares of Restricted Stock shall lapse as provided in Section 4 hereof.  All certificates representing the shares of Restricted Stock shall have endorsed thereon the following legend (in addition to any other legends that are customary or required on certificates representing shares of the Company’s Common Stock):
“THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO RESTRICTIONS ON TRANSFER AND OTHER TERMS AND CONDITIONS (INCLUDING FORFEITURE) SET FORTH IN A RESTRICTED STOCK AWARD AGREEMENT DATED AS OF ___________________, 20__, BETWEEN THE COMPANY AND THE REGISTERED HOLDER, A COPY OF WHICH IS ON FILE AT THE PRINCIPAL OFFICE OF THE COMPANY.  ANY TRANSFER OR PURPORTED TRANSFER OF THE SHARES REPRESENTED BY THIS CERTIFICATE IN VIOLATION OF SUCH RESTRICTED STOCK AWARD AGREEMENT SHALL BE NULL AND VOID.”
If and when the restrictions imposed herein on the transfer of shares of Restricted Stock shall have lapsed as provided in Section 4 hereof, certificates for such shares without the restricted stock legend set 

forth in this section shall be delivered to the Employee.  Until such restrictions have lapsed, any certificates representing any shares of Restricted Stock shall be held in custody by the Company.  Employee may request the removal of such restricted stock legend from certificates representing any shares of Restricted Stock as to which the restrictions imposed herein on the transfer thereof shall have lapsed as provided in Section 4 hereof.  Such request shall be in writing to the General Counsel of the Company.  
4.    Lapse of Restrictions and Forfeiture.  Subject to Section 4(c) hereof, the restrictions on transfer imposed on the shares of Restricted Stock by this Section 4 shall lapse with respect to the shares of Restricted Stock and the Employee will vest, or gain actual “ownership” of the shares of Restricted Stock in accordance with the terms of Sections 4(a) or (b) hereof.
(a)    Restricted Stock Time Vesting.  _______ percent (__%) of the shares of Restricted Stock awarded hereunder, consisting of __________ shares (“Time Vesting Restricted Stock”), shall vest as of the dates and in the amounts set forth below provided that Employee is employed on such date by the Company or its Affiliates or Subsidiaries:
A.    _____________ shares and representing _________ of the Time Vesting Restricted Stock, shall vest on _____________;

B.    _____________ shares and representing _________ of the Time Vesting Restricted Stock, shall vest on _____________; and

C.    _____________ shares and representing _________ of the Time Vesting Restricted Stock, shall vest on _____________.

(b)    Restricted Stock Performance Vesting.  ___________ percent (__%) of the shares of Restricted Stock awarded hereunder, consisting of __________ shares (“Performance Vesting Restricted Stock”), shall vest as of the dates and in the amounts set forth below provided that Employee is employed on such date by the Company or its Affiliates or Subsidiaries:
A.    First Tranche Amount.  The “First Tranche Amount” consisting of _____________ shares and representing _______ of the Performance Vesting Restricted Stock shall vest on ____________ (i) pursuant to the satisfaction of the applicable performance based metric of Free Cash Flow, as set forth in the ______ Long-Term Incentive Plan Guidelines or (ii) pursuant to the satisfaction of such other applicable performance criteria and schedule determined by the Board of Directors of the Company (the “Board”) or the Compensation Committee of the Company’s Board of Directors (“Compensation Committee”);

B.    Second Tranche Amount.  The “Second Tranche Amount” consisting of _____________ shares and representing ________ of the Performance Vesting Restricted Stock, shall vest on ___________, (i) pursuant to the satisfaction of the applicable performance based metric of Free Cash Flow, as set forth in the ____ Long-Term Incentive Plan Guidelines or (ii) pursuant to the satisfaction of such other applicable performance criteria and schedule determined by the Board or the Compensation Committee; and

C.    Third Tranche Amount.  The “Third Tranche Amount” consisting of _____________ shares and representing ________ of the Performance Vesting Restricted Stock, shall vest on ________, (i) pursuant to the satisfaction of the applicable performance based metric of Free Cash Flow, as set forth in the ____ Long-Term Incentive Plan Guidelines or (ii) pursuant to the 

satisfaction of such other applicable performance criteria and schedule determined by the Board or the Compensation Committee.

D.    Forfeiture of Unearned Restricted Stock.  In the event that any shares of Performance Vesting Restricted Stock do not vest pursuant to any of Subsection A, B or C of this Section 4(b), then such Performance Vesting Restricted Stock shall be forfeited and canceled as of such date.
   
(c)    Notwithstanding anything to the contrary in Sections 4(a) or (b), in the event that prior to the lapse of restrictions on transfer pursuant to Sections 4(a) or (b), Employee’s employment with all of the Company, its Affiliates and Subsidiaries is terminated for any reason other than death or Disability, Employee shall forfeit, on the date on which his employment is terminated, all of the shares of Restricted Stock as to which the restrictions on transfer imposed thereon by Section 3 hereof shall not have lapsed prior to such date.  
(d)    Notwithstanding anything to the contrary in Sections 4(a) or (b) hereof, in the event of a Change in Control, the restrictions on transfer imposed by Section 3 on the shares of Restricted Stock shall lapse.  For purposes of this Agreement, a “Change in Control” shall mean the occurrence of any of the following events, each of which shall be determined independently of the others:  (i) any “Person” (as hereinafter defined), other than a holder of at least 10% of the outstanding voting power of the Company as of the date of this Agreement, becomes a “beneficial owner” (as such term is used in Rule 13d-3 promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) of a majority of the stock of the Company entitled to vote in the election of directors of the Company; (ii) individuals who are Continuing Directors of the Company (as hereinafter defined) cease to constitute a majority of the members of the Board; (iii) stockholders of the Company adopt and consummate a plan of complete or substantial liquidation or an agreement providing for the distribution of all or substantially all of the assets of the Company; (iv) the Company is a party to a merger, consolidation, other form of business combination or a sale of all or substantially all of its assets, with an unaffiliated third party, unless the business of the Company following consummation of such merger, consolidation or other business combination is continued following any such transaction by a resulting entity (which may be, but need not be, the Company) and the stockholders of the Company immediately prior to such transaction hold, directly or indirectly, at least a majority of the voting power of the resulting entity; provided, however, that a merger or consolidation effected to implement a recapitalization of the Company (or similar transaction) shall not constitute a Change in Control; (v) there is a Change in Control of the Company of a nature that is reported in response to item 5.01 of Current Report on Form 8-K or any similar item, schedule or form under the Exchange Act, as in effect at the time of the change, whether or not the Company is then subject to such reporting requirements; provided, however, that for purposes of this Agreement a Change in Control shall not be deemed to occur if the Person or Persons deemed to have acquired control is a holder of at least 10% of the outstanding voting power of the Company as of the date of this Agreement; or (vi) the Company consummates a transaction which constitutes a “Rule 13e-3 transaction” (as such term is defined in Rule 13e-3 of the Exchange Act) prior to the termination or expiration of this Agreement.

(e)    In the event of a Rule 13e-3 transaction, then effective coincident with the consummation of such Rule 13e-3 transaction, the restrictions on transfer imposed by Section 3 on the shares of Restricted Stock shall lapse; provided, however, that notwithstanding the foregoing, in connection with the consummation of such Change in Control or Rule 13e-3 transaction, all such unvested shares of Restricted Stock then held by Employee shall be deemed to vest and become exercisable at such time in order to permit Employee to participate in such transaction. 

(f)    In the event that Employee is an employee of Covanta, then the references to the Company in Section 4(d)(i), (iii), (iv), (v) and (vi) above shall also include, in the alternative, Covanta.

(g)    For purposes of this Section 4, “Continuing Directors” shall mean the members of the Board on the date of execution of this Agreement, provided that any person becoming a member of the Board subsequent to such date whose election or nomination for election was supported by at least a majority of the directors who then comprised the Continuing Directors shall be considered to be a Continuing Director; and the term “Person” is used as such term is used in Sections 13(d) and 14(d) of the Exchange Act.

5.    Transferability.  Notwithstanding anything contained in this Agreement to the contrary, shares of Restricted Stock are not transferable or assignable by the Employee until the restrictions thereon have lapsed.  
6.    Adjustment Provisions. If, during the term of this Agreement, there shall be any merger, reorganization, consolidation, recapitalization, stock dividend, stock split, rights offering or extraordinary distribution with respect to the Common Stock, or other change in corporate structure affecting the Common Stock, the Committee shall make or cause to be made an appropriate and equitable substitution, adjustment or treatment with respect to the Restricted Stock, including a substitution or adjustment in the aggregate number or kind of shares subject to this Agreement, notwithstanding that the Restricted Stock are subject to the restrictions on transfer imposed by Section 3 above.  Any securities, awards or rights issued pursuant to this Section 6 shall be subject to the same restrictions as the underlying Restricted Stock to which they relate.
7.    Tax Withholding.  As a condition precedent to the receipt of any shares of Restricted Stock hereunder, Employee agrees to pay to the Company, at such times as the Company shall determine, such amounts as the Company shall deem necessary to satisfy any withholding taxes due on income that Employee recognizes as a result of (i) the lapse of the restrictions imposed by Section 3 hereof on the shares of Restricted Stock or (ii) Employee’s filing of an election pursuant to Section 83(b) of the Internal Revenue Code of 1986 (the “Code”), as amended, with respect to the shares of Restricted Stock.  The obligations of the Company under this Agreement and the Plan shall be conditional on such payment or arrangements, and the Company, its Affiliates and Subsidiaries shall, to the extent permitted by law, have the right to deduct any such taxes from any payment otherwise due to the Employee.  In addition, Employee may elect, unless otherwise determined by the Compensation Committee, to satisfy the withholding requirement by having the Company withhold shares of vested Restricted Stock with a Fair Market Value, as of the date of such withholding, sufficient to satisfy the withholding obligation.
8.    Registration.  This grant is subject to the condition that if at any time the Board or Compensation Committee shall determine, in its discretion, that the listing of the shares of Common Stock subject hereto on any securities exchange, or the registration or qualification of such shares under any federal or state law, or the consent or approval of any regulatory body, shall be necessary or desirable as a condition of, or in connection with, the grant, receipt or delivery of shares hereunder, such grant, receipt or delivery will not be effected unless and until such listing, registration, qualification, consent or approval shall have been effected or obtained free of any conditions not acceptable to the Board or Compensation Committee.  The Company agrees to make every reasonable effort to effect or obtain any such listing, registration, qualification, consent or approval.
9.    Rights of Employee.  In no event shall the granting of the Restricted Stock or the other provisions hereof or the acceptance of the Restricted Stock by Employee interfere with or limit in any way the right of the Company, an Affiliate or Subsidiary to terminate Employee’s employment at any time, nor confer upon Employee any right to continue in the employ of the Company, an Affiliate or Subsidiary for any period of time or to continue his or her present or any other rate of compensation.

10.    Construction.
(a)    Successors.  This Agreement and all the terms and provisions hereof shall be binding upon and shall inure to the benefit of the parties hereto and their respective legal representatives, heirs and successors, except as expressly herein otherwise provided.
(b)    Entire Agreement; Modification.  This Agreement contains the entire understanding between the parties with respect to the matters referred to herein.  Subject to Section 12(c) of the Plan, this Agreement may be amended by the Board or Compensation Committee at any time.
(c)    Capitalized Terms; Headings; Pronouns; Governing Law.  Capitalized terms used and not otherwise defined herein are deemed to have the same meanings as in the Plan.  The descriptive headings of the respective sections and subsections of this Agreement are inserted for convenience of reference only and shall not be deemed to modify or construe the provisions which follow them.  Any use of any masculine pronoun shall include the feminine and vice-versa and any use of a singular, the plural and vice-versa, as the context and facts may require.  The construction and interpretation of this Agreement shall be governed in all respects by the laws of the State of Delaware.
(d)    Notices.  Each notice relating to this Agreement shall be in writing and shall be sufficiently given if delivered by registered or certified mail, or by a nationally recognized overnight delivery service, with postage or charges prepaid, to the address hereinafter provided in this Section 10.  Any such notice or communication given by first-class mail shall be deemed to have been given two business days after the date so mailed, and such notice or communication given by overnight delivery service shall be deemed to have been given one business day after the date so sent, provided such notice or communication arrives at its destination.  Each notice to the Company shall be addressed to it at its offices at 445 South Street, Morristown, New Jersey 07960 (attention: Chief Financial Officer), with a copy to the Secretary of the Company or to such other designee of the Company.  Each notice to the Employee shall be addressed to the Employee at the Employee’s address shown on the signature page hereof.
(e)    Severability.    Whenever possible, each provision of this Agreement shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Agreement or the application thereof to any party or circumstance shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the minimal extent of such provision or the remaining provisions of this Agreement or the application of such provision to other parties or circumstances.
(f)    Counterpart Execution.  This Agreement may be executed in counterparts, each of which shall constitute an original and all of which, when taken together, shall constitute the entire document.

COVANTA HOLDING CORPORATION
By:______________________________________________
Title__________________________________________

Accepted this _______________ day of
___________________________, 20__.
                                
_______________________________________                                                                                                                      

EMPLOYEE’S ADDRESS:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00234-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00234-of-00352.parquet"}]]